Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
M. Árnadóttir. (1997) Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase. Scandinavian Journal of Clinical and Laboratory Investigation 57:1, pages 1-11.
Read now
Read now
M. Arnadottir, J. Kurkus & P. Nilsson-Ehle. (1994) Different types of heparin in haemodialysis: Long-term effects on post-heparin lipases. Scandinavian Journal of Clinical and Laboratory Investigation 54:7, pages 515-521.
Read now
Read now
E. Persson & P. Nilsson-Ehle. (1990) Release of lipoprotein lipase and hepatic lipase activities. Effects of heparin and a low molecular weight heparin fragment. Scandinavian Journal of Clinical and Laboratory Investigation 50:1, pages 43-49.
Read now
Read now
Articles from other publishers (16)
Abdellah Ali, Phalisteen Sultan, Mohamed El-Napoli & Mohamed Fahmy. (2011) Lipoprotein Metabolism Abnormalities in Patients with Chronic Renal Insufficiency. Journal of Medical Biochemistry 30:1, pages 38-44.
Crossref
Crossref
Tiago R Figueira, Aníbal E Vercesi & Helena CF Oliveira. (2010) Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia. Lipids in Health and Disease 9:1.
Crossref
Crossref
KF Elliott, LM Fleeman & JS Rand. (2010) Using 20‐gauge percutaneous peripheral catheters to reliably collect serial 4‐mL blood samples from conscious dogs. Australian Veterinary Journal 88:6, pages 215-221.
Crossref
Crossref
Birgit Näsström, Bernd Stegmayr, Gunilla Olivecrona & Thomas Olivecrona. (2004) Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme. BMC Nephrology 5:1.
Crossref
Crossref
Birgit Nasstrom, Bernd G Stegmayr, Gunilla Olivecrona & Thomas Olivecrona. (2003) Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme. Journal of Laboratory and Clinical Medicine 142:2, pages 90-99.
Crossref
Crossref
Birgit Näsström, Gunilla Olivecrona, Thomas Olivecrona & Bernd G. Stegmayr. (2001) Lipoprotein lipase during continuous heparin infusion: Tissue stores become partially depleted. Journal of Laboratory and Clinical Medicine 138:3, pages 206-213.
Crossref
Crossref
Maria E. Ramirez, Martha P. McMurry, Gail A. Wiebke, Karon J. Felten, Kuishu Ren, A.Wayne Meikle & Per-Henrik Iverius. (1997) Evidence for sex steroid inhibition of lipoprotein lipase in men: Comparison of abdominal and femoral adipose tissue. Metabolism 46:2, pages 179-185.
Crossref
Crossref
François Paye, Jacques Chariot, Georges Molas, Joëlle Benessiano & Claude Rozé. (1995) Nonesterified fatty acids in acute cerulein-induced pancreatitis in the rat are they really deleteriousin vivo?. Digestive Diseases and Sciences 40:3, pages 540-545.
Crossref
Crossref
M Lilly-Stauderman, TL Brown, A Balasubramaniam & JA Harmony. (1993) Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells.. Journal of Lipid Research 34:2, pages 190-200.
Crossref
Crossref
Y. Schmitt & H. Schneider. (2006) Die Wirkung von niedermolekularem Heparin auf den Fettstoffwechsel bei chronischen Hämodialysepatienten. Lipid / Fett 94:6, pages 222-226.
Crossref
Crossref
H. Schneider & Y. Schmitt. (1991) Niedermolekulares Heparin: Wie beeinflußt es den Fettstoffwechsel bei chronischen Hämodialysepatienten?Low molecular weight heparine: Influence on blood lipids in patients on chronic hemodialysis. Klinische Wochenschrift 69:16, pages 749-756.
Crossref
Crossref
E. Persson, J. Nordenström, P. Nilsson‐Ehle, L. Hagenfeldt & J. Wahren. (2008) Plasma lipolytic activity and substrate oxidation after intravenous administration of heparin and a low molecular weight heparin fragment. Clinical Physiology 10:6, pages 573-583.
Crossref
Crossref
F.A. Ofosu & T.W. Barrowcliffe. (1990) 2 Mechanisms of action of low molecular weight heparins and heparinoids. Baillière's Clinical Haematology 3:3, pages 505-529.
Crossref
Crossref
Susan P. Williams & Edward A. Johnson. (1989) Release of lipoprotein lipase and hepatic triglyceride lipase in rats by heparin and other sulphated polysaccharides. Thrombosis Research 55:3, pages 361-368.
Crossref
Crossref
Shuichiro Hamano, Hidetada Komatsu, Shigeru Ikeda, Kaoru Takahashi, Yutaka Oguma & Nobuo Sakuragawa. (1989) Beneficial effect of low molecular weight heparin on the hemodialysis model in dogs. Thrombosis Research 55:4, pages 439-449.
Crossref
Crossref
J. Harenberg & D. L. Heene. (2006) Pharmacology and special clinical applications of low‐molecular‐weight heparins. American Journal of Hematology 29:4, pages 233-240.
Crossref
Crossref